Axon Enterprise, Inc. (AXON) shares rose 2.7% to $315.43 as of November 15, 2026, a moderate gain from the prior close of $307.11. BestStocks flagged the session as a major change for AXON. The move is tied to company news. Below, we break down what changed for AXON, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
Company News
AXON rose 2.7% in its latest session, moving from $307.11 to $315.43.
NewsLow confidence
Rel. volume
1.2×
Normal
Vs peers
—
No comparable peers
Market cap
$25.7B
NASDAQ Global Select
Analyst target
$619
+96.4% vs price
Price chart
Oct 15 – Nov 13
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Axon Enterprise, Inc. investors
For Axon Enterprise, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 2.7% session move; Axon Enterprise recovered +6.13% to $469.18 following a sharp sell-off earlier in the week tied to the company's $1.0 billion zero-coupon convertible senior notes offering announced mid-September 2026, per web sources. Weighing against that: Axon (AXON) declined 3.82% to $401.26 despite positive federal sector news; Axon Enterprise, Inc. moved -12.86% intraday from $609.49 to $531.09. Wall Street's consensus price target sits at $619.36, implying +96.4% upside from $315.43. BestStocks rates the overall signal quality low (41/100). With earnings roughly 100 days out, the next report is the most likely near-term test of the move.
AXON price reaction
AXON last traded at $315.43, up $8.32 (+2.71%) from the previous close of $307.11. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $302.54 and $438.05, and it currently sits about 10% of the way up that band.
Bullish and bearish analyst opinions on Axon Enterprise, Inc. (AXON)
The consensus analyst price target on Axon Enterprise, Inc. (AXON) is $619.36, 96.4% above the recent $315.43. Over the past 90 days analysts logged 0 upgrades, 8 maintains, and 0 downgrades. Here is how the bullish and bearish cases on AXON line up.
▲ The bullish case
+Wall Street's consensus price target of $619.36 implies +96.4% upside from $315.43.
+The Street's most bullish target is $800.00 (+153.6%).
+Positive 2.7% session move.
+Axon Enterprise recovered +6.13% to $469.18 following a sharp sell-off earlier in the week tied to the company's $1.0 billion zero-coupon convertible senior notes offering announced mid-September 2026, per web sources.
+Positive price momentum.
▼ The bearish case
−Axon (AXON) declined 3.82% to $401.26 despite positive federal sector news.
−Axon Enterprise, Inc. moved -12.86% intraday from $609.49 to $531.09.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 15, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Axon Enterprise fell 3.81% to $301.07 following Q3 2026 earnings that missed consensus on both EPS ($1.72 vs. ~$1.89–$1.90 expected) and revenue ($908.6M vs. ~$931–$935M expected), per Zacks and investor.axon.com. Management also slashed full-year 2026 revenue guidance to $3.61–$3.63 billion, removing ~$130M tied to delayed federal Dedrone counter-drone deployments. The miss was compounded by announcement of a $1.2 billion investment in drone maker Skydio, which raised concerns about near-term cash flow and margin pressure. Volume traded at 1.97x the time-adjusted historical average, signaling elevated investor reaction.
Axon Enterprise plunged 17.16% following a weaker-than-expected Q3 earnings report released today, with revenue of $908.6M missing consensus by ~$26–29M and non-GAAP EPS of $1.72 falling short of $1.88–$1.89 guidance (Benzinga). The company also cut full-year 2026 revenue guidance to $3.610–$3.630B and trimmed free cash flow targets to $350–$400M, citing delayed federal contract deployments (~$30M Dedrone miss in Q3, ~$130M pushed beyond near-term forecasts) and an accelerated inventory build. Volume surged to 1.94M shares, 8.8x the 80-minute average.
Axon Enterprise shares fell 10.10% to $381.34 as investors positioned ahead of the company's Q3 2026 earnings report, scheduled for release after market close today. According to the web_catalyst, analysts expect Q3 revenue near $931–934 million and EPS around $1.89–1.90, but high valuation multiples and sector-wide caution (including peer reactions from Motorola Solutions) triggered a defensive pullback. Volume reached 1.23 million shares, 2.26x the expected level for this time of session, indicating elevated pre-earnings activity.
Axon (AXON) declined 3.82% to $401.26 despite positive federal sector news. On October 15, the company announced significant momentum across multiple U.S. government agencies, including law enforcement, homeland security, and veteran healthcare contracts as the fiscal year closed (per PRNewswire). The sell-off occurred despite the bullish update and analyst optimism, suggesting investors may be taking profits or digesting near-term valuation concerns ahead of the November 3 earnings report. Volume of 321,478 shares ran 1.11x normal for this stage of the trading session.
Material / Earnings2026-09-22+1.6%
AXON moved -100.00% from its $460.83 open to a $459.32 close on 2026-09-22.
Axon Enterprise recovered +6.13% to $469.18 following a sharp sell-off earlier in the week tied to the company's $1.0 billion zero-coupon convertible senior notes offering announced mid-September 2026, per web sources. Volume reached 1.49M shares (3.29x historical average for this time of session), signaling elevated institutional participation in the stabilization move.
Axon announced a $1 billion offering of 0% convertible senior notes alongside reported insider selling by CEO Patrick Smith and other executives, triggering a 9.17% intraday decline to $445.25 per share (per Yahoo Finance and FMP delayed data). Convertible notes typically raise dilution concerns among investors, while insider sales signal potential valuation caution despite the company's 35% Q2 2026 revenue growth.
Axon Enterprise rose 6.17% to $538.28 following Q2 2026 earnings that showed 35.3% year-over-year revenue growth to $904.4 million, per Yahoo Finance. The gain reversed earlier weakness — the stock had declined 14.6% prior to this result — and comes despite below-average trading volume of 0.68x expected at this point in the session.
In-depth AXON event analyses
Permanent, dated analyses of AXON's most significant sessions.
AXON rose 2.7% to $315.43. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did AXON stock rise?
AXON gained 2.71% ($8.32) versus the prior close of $307.11, last trading at $315.43 on 1.2× average volume.
When is Axon Enterprise, Inc.'s next earnings date?
AXON's next earnings report is estimated for 2027-02-23 — about 100 days away.
What is the analyst price target for AXON?
The consensus analyst price target for AXON is $619.36, about 96.4% above the current $315.43. Over the past 90 days, analysts recorded 0 upgrades, 8 maintains, and 0 downgrades.
How BestStocks tracks AXON
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for AXON, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 15, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
